Future studies integrating in vivo perfusion and pimonidazole assays will be valuable to validate the functional consequences of PAK1 or PAK4 modulation on vascular normalization and hypoxia in pancreatic cancer models. Here, PAK1 is linked to familial pancreatic carcinoma.